Pasithea Therapeutics Corp. KTTA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.22% | -45.03% | -46.91% | -- | -- |
| Total Depreciation and Amortization | 0.93% | 1.29% | 2.06% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 755.34% | 513.57% | 472.12% | -- | -- |
| Change in Net Operating Assets | -654.15% | -401.19% | 79.04% | -- | -- |
| Cash from Operations | -42.39% | -33.85% | -9.25% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 200.00% | -- | -- | -- |
| Issuance of Common Stock | 652.29% | 3,667.71% | 21,322,233.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.68% | -109.92% | -109.92% | -- | -- |
| Cash from Financing | 380.06% | 935.49% | 1,306.03% | -- | -- |
| Foreign Exchange rate Adjustments | -39.39% | 2,568.42% | 852.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,236.32% | 777.26% | 613.77% | -- | -- |